Study guide
5.1 Solution Containers, Administration Sets & Filters
CRNI® Exam Study Guide Certified Registered Nurse Infusion
Track your progress as you read
Finished sections get a check mark.
1 Introduction & Exam Overview
1.1 Current Exam Facts 1.2 Eligibility, Application & Testing Windows 1.3 Scoring, Results & Recertification
2 Anatomy & Physiology for Infusion Practice
2.1 Vascular Anatomy & Physiology for Infusion 2.2 Body Positioning for Catheter Insertion & Removal 2.3 Vein Selection & Patient Assessment
3 Infection Prevention & Control
3.1 Infection Prevention Strategies & Standard Precautions 3.2 Chain of Infection in Infusion Practice 3.3 Bloodstream Infections & CLABSI Prevention 3.4 Phlebitis: Prevention, Grading & Management
4 Phlebotomy in Infusion Practice
4.1 Blood Sampling & Blood Culture Collection 4.2 Therapeutic Phlebotomy
5 Infusion Equipment & Technology
5.1 Solution Containers, Administration Sets & Filters 5.2 Add-on Devices, Administration Devices & Closed Systems 5.3 Vein Location Devices, Navigation Tools & Securement
6 Peripheral Venous Access Devices
6.1 Short & Long Peripheral Intravenous Catheters 6.2 Midline Catheters 6.3 Peripheral Device Selection Criteria
7 Central Venous Access Devices
7.1 Peripherally Inserted Central Catheters (PICC) 7.2 Non-tunneled Central Venous Catheters 7.3 Tunneled Central Venous Catheters 7.4 Implanted Ports
8 Alternate Access Routes & Device Maintenance
8.1 Subcutaneous Infusion Access 8.2 Intraosseous Access 8.3 Device Maintenance & Care Protocols
9 Special Populations in Infusion Therapy
9.1 Older Adults & Chronic Renal Conditions 9.2 Pediatrics, Immunocompromised, Oncology & Bariatrics
10 Device-Related Complications
10.1 Infiltration & Extravasation 10.2 Catheter Occlusion 10.3 Thrombosis, Air Embolism & Device-Related Systemic Events
11 Fluid & Electrolyte Balance
11.1 Body Composition & Fluid Balance 11.2 Fluid Volume Excess & Deficit 11.3 Electrolyte Disorders 11.4 Maintenance & Replacement Fluids
12 Parenteral Nutrition
12.1 Parenteral Nutrition: Solution Composition 12.2 PN Infectious, Metabolic & Mechanical Complications
13 Anti-infectives, Blood Products & Biologics
13.1 Anti-infective Infusion Therapy 13.2 Blood Products & Transfusion Therapy 13.3 Biologics & Immunologic Therapies
14 Antineoplastic, Cardiovascular & Pain Infusions
14.1 Antineoplastic Infusion Therapy 14.2 Cardiovascular Infusions 14.3 Pain Management Infusions
15 Therapy-Related Complications & Hazardous Drugs
15.1 Rate-Related Complications 15.2 Adverse Drug Reactions 15.3 Hazardous Drug Exposure & Waste Disposal
16 Professional Practice, Documentation & Quality
16.1 Assessment, Consent & Collaborative Care Planning 16.2 Documentation, Laws & Regulatory Agencies 16.3 Evidence-Based Practice & Performance Improvement
5.1 Solution Containers, Administration Sets & Filters
Key Takeaways Explain This Topic AI
Match container material to the drug: glass or non-PVC/non-DEHP systems for DEHP-leaching or container-incompatible agents; protect light-sensitive meds and use appropriate overwraps.
Glass and rigid containers require vented administration sets (or an open vent) to prevent vacuum lock; flexible plastic bags usually run with non-vented sets.
Primary/secondary (piggyback) setups place the secondary container higher so it infuses first; a back-check valve on the primary line prevents secondary fluid from flowing up into the primary bag.
Filter selection is drug- and product-specific: 0.22-micron filters for many aqueous solutions; 1.2-micron for lipid emulsions and most 3-in-1 PN; blood sets typically use 170–260-micron clot filters.
Never assume “smaller is safer”—some medications (e.g., certain proteins, emulsions, or labeled products) are filter-incompatible; always follow manufacturer and facility policy.
Last updated: August 2026
Why containers, sets, and filters matter on the CRNI exam
Domain 2A.1 Technology & Clinical Applications tests whether you can select and troubleshoot the delivery system , not only the catheter. Wrong container material, unvented glass, a secondary bag hung lower than the primary, or a 0.22-micron filter on a lipid emulsion can stop therapy, deliver wrong rates, damage product, or harm the patient. This section links product chemistry to hardware choices.
- Solution containers: glass vs plastic
- Glass containers
Glass bottles remain in use for some medications and specialty products. Advantages include inertness for certain agents and a rigid structure that does not collapse. Disadvantages include breakability, weight, and the need for air entry as fluid leaves the bottle. If air cannot enter, a vacuum forms, flow slows or stops, and pumps may alarm for upstream occlusion.
Clinical implication: Glass (and other rigid containers) generally requires a vented administration set or an open bottle vent so atmospheric air replaces withdrawn fluid. Exam stems often show “glass bottle of [drug] on a non-vented set—flow stops.”
Plastic containers
Flexible plastic bags (often multilayer films) collapse as they empty, so they usually run on non-vented sets. Plastic systems reduce break risk and simplify transport. Not all plastics are equal:
- Concern What it means Nursing action
- PVC Polyvinyl chloride tubing/bags common in legacy sets Check drug compatibility with PVC contact
DEHP Plasticizer that can leach into some lipophilic solutions Prefer DEHP-free / non-PVC for lipids, some chemo, and DEHP-sensitive populations when policy requires
Sorption/adsorption Drug sticks to or is absorbed by container/tubing (classic examples include some nitroglycerin and insulin scenarios) Use manufacturer-recommended container/set; may need special tubing or glass
Light sensitivity Photodegradation of drug (e.g., some vitamins, certain chemo agents, nitroprusside historically) Use light-protective bags/covers and amber sets per product labeling
DEHP/PVC takeaway for CRNI: Do not memorize every drug list—memorize the principle . Lipophilic infusions and products with known container incompatibility drive non-PVC / DEHP-free selection. Pediatrics and long-duration exposures raise the stakes for plasticizer exposure in institutional policy.
Light-sensitive medications
Protect from light from preparation through infusion when labeling requires it. That may include opaque overwraps, amber tubing, and covering the drip chamber. Removing the overwrap “just to hang faster” is an exam trap if the product is still light-sensitive after compounding.
Air-in-line considerations
Glass/rigid + poor venting: flow failure and pump alarms; forced workarounds that open the system increase contamination risk.
Large air in tubing: risk of air embolism is highest with central access and larger air volumes—prime carefully, use air-eliminating filters when indicated by product/set design, and follow pump air-detection limits.
Vented sets on plastic bags: usually unnecessary; incorrect venting practices can invite contamination if vents are mishandled.
- Administration sets: primary, secondary, and connectors
- Primary sets
The primary administration set spikes the main continuous fluid (or connects to a pump cassette/module depending on system). Features may include drip chamber, roller clamp, injection ports or integrated needleless connectors, back-check valve (especially if secondary use is planned), and distal Luer lock.
Secondary (piggyback) sets
Secondary sets deliver intermittent medications into the primary line. Safe piggyback principles:
Hang the secondary container higher than the primary so gravity (or pump secondary mode) prefers secondary flow.
Connect into a proximal primary port (above a back-check valve when present) so secondary fluid does not back up into the primary bag.
Use a back-check valve on the primary line: when secondary pressure/head is higher, the valve closes toward the primary bag, preventing mixture up the primary container.
After secondary completes, primary resumes automatically in a correct setup (verify clamp positions and pump programming).
Lowering the secondary bag or leaving the primary roller clamp closed incorrectly are classic failure modes.
Needleless connectors
Needleless connectors protect staff from needlestick and provide a closed access surface. Performance depends on design (negative, positive, or neutral displacement) and, more importantly, on disinfection before every access and correct flush/clamp sequences per product IFU. Technology never replaces hub hygiene.
Set change intervals (principles, not one magic number)
INS standards and facility policy—not exam folklore—govern change times. High-yield principles:
Change sets on a timed schedule and immediately if contamination, integrity failure, or product-specific rules apply.
Blood and lipid products often have shorter set-use windows than clear crystalloids.
Continuous vs intermittent use, closed system integrity, and multi-dose secondary tubing reuse policies vary—follow policy and manufacturer labeling.
Do not invent “change only when empty” as a universal rule.
Gravity vs electronic pump
Mode Drivers Risks if mismanaged
Gravity Drop factor, roller clamp, bag height, patient position, catheter patency Free-flow if roller left open; rate drift with position changes
Pump Programmed mL/hr, secondary modes, pressure limits Wrong drug library entry, free-flow if set not loaded correctly, override of soft limits
Pumps do not eliminate need to verify the right fluid, rate, and route . Gravity still requires calculation skill (mL/hr ↔ gtt/min using drop factor).
- Filters: micron ratings and clinical matching
- 0.22-micron (0.2-micron) filters
Often used for bacteria-retentive filtration of many aqueous solutions and some PN amino acid/dextrose formulations without lipid when policy and product allow. They can trap bacteria and particulate matter. They are not appropriate for all products—lipid particles and some drug aggregates may be removed or cause filter occlusion.
1.2-micron filters
Standard choice for lipid emulsions and many 3-in-1 (total nutrient admixture) PN formulations because lipid droplets can be retained or disrupted by tighter filters. Using a 0.22-micron filter on lipids is a high-yield exam error (filter clogging, altered emulsion).
Blood administration filters
Transfusion sets typically include an in-line clot/debris filter , commonly in the 170–260 micron range (exact rating is product-specific). These remove gross clots and debris—they are not the same as 0.22-micron bacterial filters. Do not add incompatible secondary filters unless blood bank/product instructions allow.
When filters are contraindicated or cautioned
Some medications must not be filtered (or require a specific filter only) because the active product is retained, denatured, or incomplete. Examples often cited in practice include certain protein/monoclonal products, some emulsions, and any drug whose labeling says “do not filter” or specifies a unique micron size. Always read the package insert and pharmacy label. If the filter occludes repeatedly, stop and investigate compatibility/precipitation—do not force fluid through a blocked filter.
Air-eliminating filters
Some sets include air-eliminating capability as a safety feature. They complement—not replace—careful priming, especially with central lines.
Putting selection together: a practical sequence
Identify drug/product requirements (container, light, DEHP/PVC, filter, rate control).
Choose container type and confirm vented vs non-vented set.
Assemble primary/secondary with correct heights and back-check valve use.
Select filter micron rating only when indicated and compatible.
Program pump or set gravity rate; verify free-flow protection on pump sets.
Label lines, document lot/time per policy, and plan set change timing.
- Exam traps to memorize
- Non-vented set on a glass bottle → vacuum lock / no flow
- Secondary bag hung lower than primary → primary runs, secondary delayed or diluted incorrectly
- Missing or bypassed back-check valve → secondary fluid contaminates primary bag
- 0.22-micron filter on lipid/3-in-1 PN → occlusion or improper filtration
- Using a standard crystalloid set change interval for blood or lipids without checking policy
- Ignoring light protection or DEHP-free requirements for labeled products
- Assuming all needleless connectors behave the same without following IFU flush/clamp sequence
Master containers, sets, and filters as a single fluid path. The next section builds on this path with add-on devices, pumps, and closed systems for hazardous drugs.